Alibaba's Damo Academy open-sources Damo Radar, a medical AI model detecting ~150 abdominal conditions from CT scans

Alibaba's Damo Academy has open-sourced Damo Radar, a vision-language AI model trained to read contrast-enhanced CT scans across 18 abdominal organs and flag 146 possible findings, including cancers. A companion study published in Science reports an average AUC of 0.913 across those 146 findings, tested against nearly 40,000 real-world exams. The reporting here is secondary (via Hacker News/SCMP); no links to the paper, code repository or model weights are provided in the source material reviewed.

If the release holds up, it puts a radiology-grade diagnostic model into the hands of any hospital, researcher or startup with the compute to run it, rather than behind a vendor licence. That matters most for lower-resource health systems and AI developers who can now build on a benchmarked base model instead of starting from scratch. The catch is that open-sourcing a model is not the same as deploying it: nothing here addresses regulatory clearance, integration into clinical workflows, or liability, so the near-term effect is on research and tooling, not on patients being diagnosed differently tomorrow.

The claim that Damo Radar "outperformed most radiologists" is asserted without a stated comparator group, reader study design or confidence intervals, so it cannot be verified from what's given. "World's first expert-level generalist medical imaging model" is a self-awarded superlative from the research team, and the idea that the training method will "extend to other imaging types" is aspiration, not demonstrated result. The secondary-source writeup also omits basic verification anchors: no link to the Science paper, the GitHub repo or the model weights.

1. 01Direct link to the Science paper and independent replication or critique of the 0.913 AUC figure and its comparator methodology
2. 02Confirmation the model weights and code are actually accessible on a public repo (e.g. Hugging Face, GitHub) with a usable licence, not just announced
3. 03Any hospital, health system or regulator (FDA, NMPA, EMA) engaging with Damo Radar for pilot use or clearance in the next 6-12 months